Merck (NYSE:MRK) Unveils New Data On Cardiovascular Advances At ACC.25 Annual Conference
Merck (NYSE:MRK) experienced a 13% increase in its stock price over the last month, aided by several significant developments. The company's upcoming presentations at the American College of ...
1 Healthcare Stock with Solid Fundamentals and 2 to Turn Down
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...
The Independent Singapore News10h
The 2027 Tour de France returns to Britain and is set to kick off in Edinburgh
Edinburgh, a city in Scotland, will be the starting point for the 2027 Tour de France, which will be returning to Britain for ...
Medical Marketing & Media18h
Rx Rundown: AstraZeneca, Pfizer, Novartis and more
AstraZeneca signed a deal with Alteogen worth up to $1.35 billion for subcutaneous cancer drugs. Taiho Pharmacetical bought ...
Former Texas congressman Burgess eyed as CDC director nominee - report
The White House is reportedly considering former U.S. Rep. Michael Burgess (R-Texas) as its nominee to head the CDC. Burgess, ...
Investor's Business Daily on MSN22h
Is Moderna Stock A Sell As RFK Jr. Reportedly Mulls A Massive Funding Pull?
Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock a sell?